Terbinafine hydrochloride CAS:78628-80-5

Terbinafine hydrochloride is indicated for the treatment of various fungal infections, including athlete's foot (tinea pedis), ringworm (tinea corporis), jock itch (tinea cruris), and fungal infections of the nails (onychomycosis). It is available in oral and topical formulations, allowing for flexible and convenient administration depending on the location and severity of the infection. For dermatophyte infections of the skin, topical terbinafine cream or gel is typically applied once or twice daily for several weeks until the infection resolves. In cases of onychomycosis, oral terbinafine tablets are often prescribed for a duration of several weeks to months, depending on the extent of nail involvement and patient response. Adverse effects associated with terbinafine hydrochloride therapy are generally mild and transient, including gastrointestinal upset, headache, and skin reactions. Rare but serious adverse effects such as liver toxicity and neutropenia have been reported, necessitating periodic monitoring of liver function and blood counts during treatment. Patients should be instructed to adhere to the prescribed regimen and complete the full course of treatment to achieve optimal therapeutic outcomes and reduce the risk of recurrence. Consulting with a healthcare professional is recommended for personalized treatment recommendations and guidance on managing side effects to ensure safe and effective use of terbinafine hydrochloride in fungal infections.